Phlorotannins in Ecklonia cava extract inhibit matrix metalloproteinase activity

被引:149
作者
Kim, Moon-Moo
Van Ta, Quang
Mendis, Eresha
Rajapakse, Niranjan
Jung, Won-Kyo
Byun, Hee-Guk
Jeon, You-Jin
Kim, Se-Kwon [1 ]
机构
[1] Pukyong Natl Univ, Marine Bioproc Res Ctr, Pusan 608737, South Korea
[2] Pukyong Natl Univ, Dept Chem, Pusan 608737, South Korea
[3] Kangnung Natl Univ, Fac Marine Biosci & Technol, Gangwon 210702, South Korea
[4] Jeju Natl Univ, Dept Marine Sci, Cheju 690756, South Korea
关键词
matrix metalloproteinase; Ecklonia cava; gelatin zymography; HT1080; cells; human dermal fibroblasts;
D O I
10.1016/j.lfs.2006.04.022
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Matrix metalloproteinase (MMP) inhibitors have been identified as potential therapeutic candidates for metastasis, arthritis, chronic inflammation and wrinkle formation. For the first time here we report a detailed study on the inhibitory effects of phlorotannins in brown algae, Ecklonia cava (EC) on MMP activities in cultured human cell lines. A novel gelatin digestion assay could visualize complete inhibition of bacterial collagenase-1 activity at 20 mu g/ml of EC extract during preliminary screening studies. Sensitive fluorometric assay revealed that EC extract can specifically inhibit both MMP-2 and MMP-9 activities significantly (P < 0.001) at 10 mu g/ml. In addition, artificially induced activities of MMP-2 and MMP-9 in human dermal fibroblasts and HT1080 cells were inhibited by EC extract in a more or less similar manner to the positive control doxycycline. Even though the expression levels of MMPs differ from one cell type to the other, gelatin zymography clearly revealed that both MMP expression and activity in cells can be inhibited by EC extract. More interestingly, EC extract did not exert any cytotoxic effect even at 100 mu g/ml anticipating its potential use as a safe MMP inhibitor. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:1436 / 1443
页数:8
相关论文
共 32 条
[1]   Inhibition of HIV-1 reverse transcriptase and protease by phlorotannins from the brown alga Ecklonia cava [J].
Ahn, MJ ;
Yoon, KD ;
Min, SY ;
Lee, JS ;
Kim, JH ;
Kim, TG ;
Kim, SH ;
Kim, NG ;
Huh, H ;
Kim, J .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2004, 27 (04) :544-547
[2]  
AIMES RT, 1995, BIOL CHEM, V270, P5872
[3]   Age-related differences in the temporal and spatial regulation of matrix metalloproteinases (MMPs) in normal skin and acute cutaneous wounds of healthy humans [J].
Ashcroft, GS ;
Horan, MA ;
Herrick, SE ;
Tarnuzzer, RW ;
Schultz, GS ;
Ferguson, MWJ .
CELL AND TISSUE RESEARCH, 1997, 290 (03) :581-591
[4]   Clinical trials of a matrix metalloproteinase inhibitor in human periodontal disease [J].
Ashley, RA .
INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS, 1999, 878 :335-346
[5]   Convenient fluorometric assay for matrix metalloproteinase activity and its application in biological media [J].
Beekman, B ;
Drijfhout, JW ;
Bloemhoff, W ;
Ronday, HK ;
Tak, PP ;
Koppele, JMT .
FEBS LETTERS, 1996, 390 (02) :221-225
[6]   MATRIX METALLOPROTEINASES - A REVIEW [J].
BIRKEDALHANSEN, H ;
MOORE, WGI ;
BODDEN, MK ;
WINDSOR, LJ ;
BIRKEDALHANSEN, B ;
DECARLO, A ;
ENGLER, JA .
CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 1993, 4 (02) :197-250
[7]   Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology [J].
Chakrabarti, S ;
Patel, KD .
EXPERIMENTAL LUNG RESEARCH, 2005, 31 (06) :599-621
[8]   New functions for the matrix metalloproteinases in cancer progression [J].
Egeblad, M ;
Werb, Z .
NATURE REVIEWS CANCER, 2002, 2 (03) :161-174
[9]  
FUKUYAMA Y, 1990, CHEM PHARM BULL, V38, P133
[10]  
Golub L M, 1998, Adv Dent Res, V12, P12